<br><br><div class="gmail_quote">On Sun, Mar 11, 2012 at 9:48 PM, Marc Couture <span dir="ltr"><<a href="mailto:jaamcouture@gmail.com">jaamcouture@gmail.com</a>></span> wrote:<br><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex">
On Feb 29, 2012, Karen Shashok wrote in EASE-forum:<br><br>><br>> Fake journals, fake conferences, and now an online outfit that is charging for access to<br>> articles published in open access journals!<br>><br>
> <a href="http://www.newsrx.com/newsletters/health-and-medicine-week/2008-05-12/200512200820915W.html" target="_blank">http://www.newsrx.com/newsletters/health-and-medicine-week/2008-05-12/200512200820915W.html</a> <br>
</blockquote><div> </div><blockquote class="gmail_quote" style="margin:0pt 0pt 0pt 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">This makes an interesting case study in light of the debate on "libre" OA.<br>
<br>First, there seems to be nothing illegal, at least in matters of copyright, in selling this article. BMC papers are published under the most "libre" CC license (CC-BY), which "permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited". In particular, commercial uses are allowed, the idea being that someone can ask money for an OA article only if they offer some added value, because anyone can access the article for free.<br>
<br>But I had always wondered if some unscrupulous third parties could succeed in making people pay for OA articles simply by hiding the fact that they are freely available elsewhere.<br><br>So the issue here is more a matter of false representation (which is unethical, and could well be illegal). The "new" article begins in the same way as articles in science news media: "According to recent research from Granada, Spain...". But then this is followed (between quotes) by the exact beginning of Ms Shashok’s paper, and one has to pay to see if the remaining of the article is also just an exact copy of the whole original paper. As a matter of principle, I didn't want to pay the fee, even if it's small, just to verify, but I suspect the added value to be close to zero.<br>
<br></blockquote><div>I would agree that CC-BY is aimed at allowing downstream users to do almost anything with the material except pretend they wrote it (an as such I use it whenever possible).<br> <br></div><div>The particularly pernicious part of this is that it seems to be aimed at patients who are unlikely to understand the nuances of Open Access and the way that academia works. They are not going to search Google for particular papers (which is how most people would discover papers in Institutional Repositories (whether CC-BY or - the majority - not)). They will happen on this site (which probably has lots of papers of this sort) from popular medical sites.<br>
<br>Note that selling freely available information and services is a widespread business model. In the UK there are many firms that sell services to claim back from the latest insurance misselling when there is a completely free government service.<br>
<br></div><blockquote class="gmail_quote" style="margin:0pt 0pt 0pt 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">There is also the question of complying with the terms of the CC license: one could argue that, in order that the original paper be "properly" cited, the complete BMC reference should be given, including a hyperlink to the (gratis) original article. Maybe there is such a reference in the part of the article which is not displayed; this would technically satisfy the license requirements, but the ethical issue would remain the same.<br>
<br>According to Peter Suber (<a href="http://www.earlham.edu/%7Epeters/fos/newsletter/07-02-11.htm" target="_blank">http://www.earlham.edu/~peters/fos/newsletter/07-02-11.htm</a>), about half of the 22% of OA journals using CC licenses have chosen the CC-BY version. The others often add the NC (non-commercial) restriction, maybe to avoid this kind of questionable business practices. But there is a price to pay, which is that legitimate commercial uses may be impeded by the NC restriction.<span class="HOEnZb"><font color="#888888"><br>
</font></span></blockquote><div> </div><div>I don't think NC would stop them. They'll probably simply get people to pay for the link.<br><br>IMO publishers are seriously abusing "Open Access". The latest Wiley offering (3000 Eur, CC-NC, hand copyright to Wiley, accept further restrictions on what papers are posted and what can be done with them) leaves me speechless (<a href="http://blogs.ch.cam.ac.uk/pmr/2012/03/04/wiley%E2%80%99s-%E2%80%9Cfully-open-access%E2%80%9D-chemistry-open-my-review-if-this-is-%E2%80%9Cgold-oa%E2%80%9D-i-don%E2%80%99t-want-it/">http://blogs.ch.cam.ac.uk/pmr/2012/03/04/wiley%E2%80%99s-%E2%80%9Cfully-open-access%E2%80%9D-chemistry-open-my-review-if-this-is-%E2%80%9Cgold-oa%E2%80%9D-i-don%E2%80%99t-want-it/</a> ). I imagine this is labelled on this list as Gold OA-libre (since we can probably find *some* permission that has been granted) and it would be in the DOAJ. Personally I think that academia has to find some way of monitoring and stamping publications because no-one else can be trusted.<br>
<br> <br></div></div><br clear="all"><br>-- <br>Peter Murray-Rust<br>Reader in Molecular Informatics<br>Unilever Centre, Dep. Of Chemistry<br>University of Cambridge<br>CB2 1EW, UK<br>+44-1223-763069<br>